Danderyd, 2012-11-06 15:56 CET (GLOBE NEWSWIRE) --
XCounter AB (publ) (Nasdaq OMX First North: XCT) ("XCounter" or the “Company”), a technology leader in direct conversion and photon counting digital X-ray imaging for medical, dental and industrial markets, announces that at the Company’s Extraordinary General Meeting (“EGM”) held earlier today all the below resolutions were duly passed.
In addition to the three current Directors of the Board, it was resolved to appoint Charles Spicer as Director of the Board for the time until the end of the next annual general meeting.
It was resolved to remunerate the Directors with SEK 130,000 for non-executive members and SEK 250,000 for the Chairman. Reasonable expenses like travel and similar costs shall be reimbursed. It was further resolved that Directors shall have the possibility to receive the compensation in the form of options instead of cash according to Board stock option plan 2012/2016 as per below. All Directors chosed options as compensation.
It was resolved to approve the Board of Directors’ resolution dated 15 October 2012, to issue a maximum of 670,000 shares.
It was resolved to approve the nomination committee of the Company’s proposal to adopt Board stock option plan 2012/2016 of a maximum of 105,000 options, to issue warrants and approve disposition of warrants within the Board stock option program.
It was resolved to approve the Board of directors proposal to adopt XCounter AB’s employee stock option plan 2012/2017 consisting of 200,000 options, to issue warrants and approve disposition of warrants within the employee stock option program.
For further details please see the press release of the Notice for EGM prior to the EGM available at the Company’s website.
For further information
Fredrik Henckel, CEO for XCounter AB, +46 8 622 23 17, +46 760 198 402
Jean-Philippe Flament, Chairman of the Board for XCounter AB
XCounter AB in summary
XCounter AB is a technology leader in direct conversion and photon counting digital X–ray imaging for medical, dental and industrial markets targeting to be the leading provider of high-end X-ray sensors. The Company’s share is traded at the stock exchange Nasdaq OMX First North. Mangold Fondkommission AB, telephone +46 8 503 015 50, is the Company’s Certified Adviser and Liquidity Provider. Further information about XCounter AB can be found at www.xcounter.se.
